Antibody-based drugs and vaccines against severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) are being expedited through preclinical and clinical development. Data …

Background The diagnostic challenges associated with the COVID‐19 pandemic resulted in
rapid development of diagnostic test methods for detecting SARS‐CoV‐2 infection. Serology …

SARS-CoV-2 enters cells using its Spike protein, which is also the main target of neutralizing
antibodies. Therefore, assays to measure how antibodies and sera affect Spike-mediated …

Here, we describe a serological enzyme-linked immunosorbent assay for the screening and
identification of human SARS-CoV-2 seroconverters. This assay does not require the …

COVID-19, caused by the SARS-CoV-2 virus, has developed into a global health crisis,
causing over 2 million deaths and changing people's daily life the world over. Current main …

Virus neutralization remains the gold standard for determining antibody efficacy. Therefore,
a high-throughput assay to measure SARS-CoV-2 neutralizing antibodies is urgently …

The SARS-CoV-2 proteome shares regions of conservation with endemic human
coronaviruses (CoVs), but it remains unknown to what extent these may be cross …

The worldwide pandemic of COVID-19 has become a global public health crisis. Various
clinical diagnosis methods have been developed to distinguish COVID-19–infected patients …

In order to properly understand the spread of SARS-CoV-2 infection and development of
humoral immunity, researchers have evaluated the presence of serum antibodies of people …

As the SARS-CoV-2 pandemic unfolds across the globe, consistent themes are emerging
with regard to aspects of SARS-CoV-2 infection and its associated disease entities in …